by American College of Physicians In the Diabetes Prevention Program (DPP) clinical trial and its long-term follow-up study, among the persons who lost at least 5 percent of their body weight during the first year, long-term maintenance of weight loss was more likely if they had been assigned to treatment with metformin than with placebo or lifestyle intervention. Being older and losing a greater amount of weight in the...
Tag: <span>Metformin</span>
Post
How an existing diabetes drug controls pancreatic cancer
New research suggests that targeting a particular cell signaling pathway with the diabetes drug metformin might offer a way to stop the progression and spread of pancreatic cancer. The study — which was led by Rutgers Cancer Institute of New Jersey in New Brunswick — is to feature at the 2018 annual meeting of the American...
Post
Metformin shows promise as a potential treatment for fragile X syndrome
An inherited form of intellectual disability called fragile X may be treatable with metformin, the most widely used type 2 diabetes drug. This was the conclusion that researchers came to after studying the social, behavioral, and biological effects of metformin in a mouse model of fragile X. Research has shown that metformin, a drug used...